Aeterna Zentaris
AEZS
$2.79
Share price
0.54%
Change (1 day)
-46.86%
Change (1 year)
Categories
Aeterna Zentaris (AEZS) - Cash on Hand
Cash on Hand as of December 2022 : $50.61 M
According to Aeterna Zentaris's latest financial reports the company has $50.61 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Aeterna Zentaris - Cash on Hand chart (from 2001 to 2022)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2021-12-31 | $65.3 M | 169.05% |
| 2020-12-31 | $24.27 M | 209.66% |
| 2019-12-31 | $7.83 M | -45.99% |
| 2018-12-31 | $14.51 M | 86.53% |
| 2017-12-31 | $7.78 M | -64.63% |
| 2016-12-31 | $21.99 M | -46.93% |
| 2015-12-31 | $41.45 M | 18.66% |
| 2014-12-31 | $34.93 M | -19.14% |
| 2013-12-31 | $43.2 M | 9.31% |
| 2012-12-31 | $39.52 M | -15.7% |
| 2011-12-31 | $46.88 M | 38.16% |
| 2010-12-31 | $33.93 M | -10.94% |
| 2009-12-31 | $38.1 M | -23.37% |
| 2008-12-31 | $49.71 M | 20.13% |
| 2007-12-31 | $41.38 M | -32.17% |
| 2006-12-31 | $61.01 M | 15.77% |
| 2005-12-31 | $52.7 M | 9.07% |
| 2004-12-31 | $48.32 M | -2.65% |
| 2003-12-31 | $49.63 M | -4.16% |
| 2002-12-31 | $51.79 M | 52.5% |
| 2001-12-31 | $33.96 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $12.26 B | 24,123.98% | 🇨🇭 Switzerland |
 Sanofi SNY | $14.35 B | 28,255.50% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | $8.99 B | 17,672.82% | 🇺🇸 USA |
 Spectrum Pharmaceuticals
SPPI | $75.09 M | 48.38% | 🇺🇸 USA |
 Halozyme Therapeutics HALO | $0.36 B | 616.83% | 🇺🇸 USA |